Skip to main content
Premium Trial:

Request an Annual Quote

ABI Stops Selling HTS Biosystems SPR Array Platform

NEW YORK, Oct. 5 (GenomeWeb News) - Applied Biosystems will no longer develop, service, or distribute HTS Biosystems' surface plasmon resonance array platform, HTS said today.

 

From now on, the platform, sold as the 8500 Affinity Chip Analyzer by ABI, will be marketed by HTS Biosystems as the Flexchip Kinetic Analysis System.

 

As a result of its ongoing business review, ABI decided to stop selling the instrument. "Although we have had a successful relationship with Applied Biosystems, we understand their future market emphasis, and agree that the Flexchip system's success is best served through specific market focus by HTS," said Gregory Freitag, HTS' CEO, in a company statement.

 

The two companies first agreed to bring the instrument to market  in 2002.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.